Skip to main content

$0.130 0.025 (23.81%)

High

$0.13

Low

$0.11

Trades

273

Turnover

$1,647,025

Volume

13,196,801
30 June 2023 at 4:45pm
Register to track BOT and receive email alerts.
Subject
BOT Ann: Application for quotation of securities - BOT

BOT Ann: NDA Filing Accelerated and Trials Fully Enrolled

BOT Ann: Investor Presentation

BOT Ann: Botanix Investor Webinar

BOT Ann: Dermatology Asset Acquired to Accelerate Path to Revenue

BOT Ann: Trading Halt

BOT Ann: Appendix 4C - Quarterly

BOT Ann: FDA Qualified Infectious Disease Product Status for BTX 1801

BOT Ann: Botanix upcoming presentation - Health Economics Conference

BOT Ann: Notification regarding unquoted securities - BOT

BOT Ann: Upcoming BTX 1801 Data Presentations at European Congress

BOT Ann: Experienced dermatology executives join Botanix

BOT Ann: Botanix receives $2.75m R&D Tax Incentive Refund

BOT Ann: Botanix to present at Switzer Virtual Investor Day

BOT Ann: Change of Director's Interest Notice DS

BOT Ann: Notification regarding unquoted securities - BOT

BOT Ann: Notification regarding unquoted securities - BOT

BOT Ann: Initial Director's Interest Notice DS

BOT Ann: Director Appointment

BOT Ann: Investor Presentation

BOT Ann: Botanix to present at ShareCafe - Hidden Gems Webinar

BOT Ann: Half Yearly Report and Accounts

BOT Ann: Change of Director's Interest Notice SW

BOT Ann: Notification of cessation of securities - BOT

BOT Ann: Appendix 4C - Quarterly

BOT Ann: Change of Registry Address

BOT Ann: Notification of cessation of securities - BOT

BOT Ann: Botanix Roadshow Presentation

BOT Ann: Results of Meeting

BOT Ann: Investor Presentation - Annual General meeting

BOT Ann: Appendix 4C - Quarterly

BOT Ann: Notification regarding unquoted securities - BOT

BOT Ann: Canine Atopic Dermatitis Program Launched

BOT Ann: Botanix Expands Management Team

BOT Ann: Letter to Shareholders - Annual General Meeting

BOT Ann: Notice of Annual General Meeting/Proxy Form

BOT Ann: Botanix Presentation Corporate Update

BOT Ann: Final Report and Annual Report to Shareholders

BOT Ann: Apendix 4G

BOT Ann: Annual General Meeting

BOT Ann: Appendix 4C - Quarterly

BOT Ann: New Canine Pilot Study Supports Further AD Investigation

BOT Ann: Updated Investor Presentation and Conference Call

BOT Ann: Botanix Update on BTX 1801 Clinical Development

BOT Ann: Appendix 4C - Quarterly

BOT Ann: Publication and Awareness boosts BOT Antimicrobial Platform

BOT Ann: BTX 1702 Rosacea Study Approval

BOT Ann: Botanix Presenting at ASX Small and Mid-Cap Conference

BOT Ann: Final Director's Interest Notice

BOT Ann: Botanix Expands Management Team

Register to track BOT and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL